Ubiquitin Conjugation of Open Reading Frame F DNA Vaccine Leads to Enhanced Cell-Mediated Immune Response and Induces Protection against Both Antimony-Susceptible and -Resistant Strains ofLeishmania donovani-Reference-Cited by-同舟云学术

Ubiquitin Conjugation of Open Reading Frame F DNA Vaccine Leads to Enhanced Cell-Mediated Immune Response and Induces Protection against Both Antimony-Susceptible and -Resistant Strains ofLeishmania donovani

Published:2009-11-23 Issue:12 Volume:183 Page:7719-7731
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Sharma Ankur,Madhubala Rentala

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. Advances in leishmaniasis

2. Special Programme for Research and Training in Tropical Diseases: Leishmaniasis. World Health Report: Thirteenth Programme Report 1997 World Health Organizations Publications, Geneva.

3. Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis

4. Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eimeria tenella 14-kDa phosphohistidine phosphatase stimulates maturation of chicken dendritic cells and mediates DC-induced T cell priming in a Th1 cytokine interface;Research in Veterinary Science;2022-12

2. Immunotherapy for visceral leishmaniasis: A trapeze of balancing counteractive forces;International Immunopharmacology;2022-09

3. A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection;Vaccines;2022-07-19

4. Review of Molecular Approaches in Leishmaniasis Vaccines: Implications and Restrictions;International Journal of Infection;2022-05-22

5. Leishmania infantum UBC1 in Metacyclic Promastigotes from Phlebotomus perniciosus, a Vaccine Candidate for Zoonotic Visceral Leishmaniasis;Vaccines;2022-02-03